Evidence map›Paper›PMID 27377586›Full record

ArticleThe Journal of experimental medicine2016

Brain-resident memory T cells represent an autonomous cytotoxic barrier to viral infection.

Karin Steinbach, Ilena Vincenti, Mario Kreutzfeldt, Nicolas Page, Andreas Muschaweckh, Ingrid Wagner, Ingo Drexler, Daniel Pinschewer, Thomas Korn, Doron Merkler

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 1 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 1 synthesis or guideline pooled it, 202 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Increased Numbers of CD4Annals of neurology · 2026
    Article
  5. Review
  6. Liver-directed AAV-IL-10 therapy enhances CD8Journal for immunotherapy of cancer · 2026
    Article
  7. Observational
  8. Review
  9. Review
  10. Review
  11. Article
  12. CD103Nature communications · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Karin SteinbachDepartement de Pathologie et Immunologie, Centre Medical Universitaire, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0001-9962-7994
Ilena VincentiDepartement de Pathologie et Immunologie, Centre Medical Universitaire, University of Geneva, 1211 Geneva, Switzerland.
Mario KreutzfeldtDepartement de Pathologie et Immunologie, Centre Medical Universitaire, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0003-0335-2733
Nicolas PageDepartement de Pathologie et Immunologie, Centre Medical Universitaire, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0002-5845-6831
Andreas MuschaweckhKlinikum rechts der Isar, Department of Experimental Neuroimmunology, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0002-6870-1378
Ingrid WagnerDepartement de Pathologie et Immunologie, Centre Medical Universitaire, University of Geneva, 1211 Geneva, Switzerland.
Ingo DrexlerInstitute of Virology, University Hospital Düsseldorf, Heinrich-Heine-University, 40225 Düsseldorf, Germany.ORCID 0000-0002-6903-9144
Daniel PinschewerDepartment of Biomedicine, University of Basel, 4056 Basel, Switzerland.
Thomas KornKlinikum rechts der Isar, Department of Experimental Neuroimmunology, Technical University of Munich, 81675 Munich, Germany Munich Cluster of Systems Neurology (SyNergy), 81377 Munich, Germany.ORCID 0000-0002-3633-0955
Doron MerklerDepartement de Pathologie et Immunologie, Centre Medical Universitaire, University of Geneva, 1211 Geneva, Switzerland Division of Clinical Pathology, Geneva University Hospital, 1211 Geneva, Switzerland doron.merkler@unige.ch.ORCID 0000-0002-0247-2007
University of Geneva · CHTUM Klinikum · DEDüsseldorf University Hospital · DEUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue-resident memory T cells (TRM) persist at sites of prior infection and have been shown to enhance pathogen clearance by recruiting circulating immune cells and providing bystander activation. Here, we characterize the functioning of brain-resident memory T cells (bTRM) in an animal model of viral infection. bTRM were subject to spontaneous homeostatic proliferation and were largely refractory to systemic immune cell depletion. After viral reinfection in mice, bTRM rapidly acquired cytotoxic effector function and prevented fatal brain infection, even in the absence of circulating CD8(+) memory T cells. Presentation of cognate antigen on MHC-I was essential for bTRM-mediated protective immunity, which involved perforin- and IFN-γ-dependent effector mechanisms. These findings identify bTRM as an organ-autonomous defense system serving as a paradigm for TRM functioning as a self-sufficient first line of adaptive immunity.

Indexed as

Cell ProliferationImmunologic MemoryAnimalsBrainCD8-Positive T-LymphocytesInterferon-gammaLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMiceMice, KnockoutIFNG protein, mouseInterferon-gamma

Identifiers

PMID27377586
PMCPMC4986533
OpenAlexW2467438710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.